The significance of the discovery of prontosil in 1932 as the initiating step in the development of the modern era of antimicrobial chemotherapy is reviewed. The history of the discovery and the development of chemotherapeutic agents, from penicillin in 1929 to present-day antibiotics, are summarized. The various mechanisms by which bacteria are able to overcome the protective effects of these therapeutic agents (from the sulphonamides to the new fluoroquinolones) and develop resistance to them are discussed in detail. Attempts to elucidate the mechanisms by which resistance to chemotherapeutic agents develops are vital to the future of antimicrobial chemotherapy.
FlemingA.On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol1929; 10: 226.
2.
ZinnerSH, MayerKH: Sulfonamides and trimethoprim. In: Principles and Practice of Infectious Diseases, 3rd edn. (MandellGL, DouglasRJr, BennettJE, eds). New York: Churchill Livingstone, 1990; pp 235–334.
3.
SchatzA, BugieE, WaksmanSA: Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. Proc Soc Exp Biol Med1944; 55: 66.
4.
FinlandM: Twenty-fifth anniversary of the discovery of aureomycin: the place of the tetracyclines in antimicrobial therapy. Clin Pharmacol Ther1974; 15: 3.
5.
EhrlichJ, BartzQR, SmithRM: Chloromycetin, a new antibiotic from a soil actinomycete. Science1947; 106: 417.
6.
CarterHE, GottliebD, AndersonHW: Comments and communications. Science1948; 107: 113.
7.
EhrlichJ, GottliebD, BurkholderPR: Streptomyces venezuelae, N. sp., the source of Chloromycetin. J Bacteriol1948; 56: 467.
8.
EhrlichJ, Shiga. In: Paul Ehrlich. Forsher fürdas Leben (BaumillerE, ed.). Darmstadt: Societats-Verlag1979
9.
EhrlichP, HataS: Chemotherapeutische Trypanosomen-Studien. Berliner Munch Tierarztl Wochenschr1907; 44: 233.
10.
DomagkG: Ein Beitrag zur Chemotherapie der bakteriellen Infection. Dtsch Med Wochenschr1935; 61: 250.
11.
TréfouëlJ: Activité du p-aminophénylsulfonamide sur les infections streptococciques expérimentales de la souris et du lapin. C R Soc Biol (Paris)1935; 120: 756–758.
12.
WoodsDD: Relation of p-aminobenzoic acid to mechanism of action of sulphanilamide. Br J Exp Pathol1949; 21: 74–90.
13.
LesherGY, FroelichEJ, GruettMD: 1,8-Naphthyridine derivative: a new class of chemotherapeutic agents. J Med Pharm Chem1962; 5: 1063.
14.
ShimizuM, TalkaseY, NakamuraS: Piromidic acid, a new antibacterial agent. Antimicrob Agents Chemother1971; 19: 117.
15.
ShimizuM, TalkaseY, NakamuraS: Pipemidic acid, a new antibacterial agent active against P. aeruginosa. Antimicrob Agents Chemother1975; 8: 767.
16.
IrikuraT: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother1980; 77: 103.
17.
KogaH: Structure – activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acid. J Med Chem1980; 23: 1358.
18.
GroheK, HeitzerH.Synthese 4-chinolon-3-carbonsauren. Liebigs Ann Chem1987; 1: 29.
19.
FildesP: Rational approach to research in chemotherapy. Lancet1940; i: 955–957.
20.
MillerAK, BrunoP, BerglundRM: The effect of sulfathiazole on the in vitro synthesis of certain vitamins by Escherichia coli. J Bacterial1947; 54: 9.
21.
MitsuhashiS: Multiple resistance of enteric bacteria and transmission of drug-resistance to other strains by mixed cultivation. Jap J Exp Med1960; 30: 179.
22.
MitsuhashiS: The R factors. J Infect Dis1969; 119: 89.
23.
MitsuhashiS: Genetics of R factors. In: Antibiotics and Chemotherapy, vol. 20 (SchönfeldH, eds). Basel: S Karger, 1976; pp 133–174.
24.
MitsuhashiS: Antibacterial activity of aminoglycoside antibiotics. In: Aminoglycosides: Microbiology, Clinical Use and Toxicology (WheltonA, NeuHD, eds); New York: Marcel Dekker, 1981, pp 97–122.
25.
MitsuhashiS (Ed.): Beta-lactam Antibiotics. New York: Springer Verlag, 1981.
26.
MitsuhashiS: Antibacterial activity of aminoglycoside antibiotics 1982. In: Handbook of Experimental Pharmacology (UmezawaH, HooperIR, eds). New York: Springer Verlag, 1982.
27.
MitsuhashiS: Bacterial Resistance, Plasmid Resistance and Chromosome-mediated Resistance (KmerleHP, ed.). New York: Georg Thieme Verlag, 1983; pp 208–260.
28.
YamashitaS, InoueM, MitsuhashiS: Antibacterial activity of ciprofloxacin. Chemotherapy1985; 33: 1.
29.
MitsuhashiS: History and progress of β-lactam antibiotics. Kolben Med1989; 10: 1–13.
30.
GellertM, MizuuchiK, O'DeaMH,: Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc Nat Acad Sci USA1977; 74: 4772.
31.
MitsuhashiS: Transmission of drug resistance among Enterobacteriaceae. Jap J Exp Med1960; 30: 289.
32.
MitsuhashiS: Elimination of transmissible drug-resistance by treatment with acriflavine. Nature1961; 189: 947.
33.
MitsuhashiS: Formation of conjugative drug resistance (R) plasmids. In: DNA Insertion Elements, Plasmids, and Episomes. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1977; pp 139–146.
34.
MitsuhashiS (Ed.): Bacterial Drug Resistance R Plasmid. Tokyo: Kodansha Press, 1980.
35.
AkibaT: Drug resistance in Shigella strains [in Japanese]. Med Jap1959; 5: 299.
36.
OchiaiK: Drug resistance in Shigella strains [in Japanese]. Clinic1960; 18: 101.
37.
MitsuhashiS: Transduction of drug-resistance in Staphylococcus aureus. Gunma J Med Sci1961; 10: 297.
38.
MitsuhashiS: Joint elimination and joint transduction of the determinants of penicillinase production and resistance to macrolide antibiotics. J Bacteriol1965; 89: 988.
39.
HashimotoH, KonoK, MitsuhashiS: Elimination of penicillin resistance of Staphylococcus aureushy treatment with acriflavine. J Bacteriol1964; 88: 261.
40.
KondoE, MitsuhashiS: Active transducing bacteriophage PI-CM produced by the combination of R factor with bacteriophage PI. J Bacteriol1964; 88: 1266.
41.
MitsuhashiS: Chromosomal location of nontransferable R factor in Escherichia coli. J Bacteriol1967; 93: 1236.
42.
MitsuhashiS (Ed.): R Factor – Drug Resistance Plasmid. New York: Springer Verlag, 1977.
